NCT02026934: CliniMACS® CD34+ Reagent System for Expanded Access Use |
|
|
| No Longer Available | N/A | | US | CliniMACS CD34 Reagent System | Joseph Antin, Miltenyi Biomedicine GmbH | Graft-Versus-Host Disease(GVHD), Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells, Graft Failure, Delayed Graft Function | | | | |